Impact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitors
José Luis Izquierdo, Pilar Resano, Abdulkader El Hachem, Desiré Graziani, Carlos Almonacid, Ignacio M Sánchez Pulmonology Department, Guadalajara University Hospital, Guadalajara, Spain Abstract: While it is relatively well known that the prognosis of patients with...
Main Authors: | Izquierdo JL, Resano P, El Hachem A, Graziani D, Almonacid C, Sánchez IM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-09-01
|
Series: | International Journal of COPD |
Online Access: | http://www.dovepress.com/impact-of-copd-in-patients-with-lung-cancer-and-advanced-disease-treat-peer-reviewed-article-COPD |
Similar Items
-
Subsequent chemotherapy reverses acquired tyrosine kinase inhibitor resistance and restores response to tyrosine kinase inhibitor in advanced non-small-cell lung cancer
by: Sun Jin, et al.
Published: (2011-03-01) -
Comparison of salvage surgeries for lung adenocarcinoma treated with anaplastic lymphoma kinase-tyrosine kinase inhibitors
by: Naoya Iwamoto, et al.
Published: (2021-12-01) -
Glycodelin As A Biomarker Of Advanced Lung Adenocarcinoma Brain Metastases In Patients Treated With EGFR Tyrosine Kinase Inhibitors
by: Ni Z, et al.
Published: (2019-11-01) -
Selection of non-small cell lung cancer patients for intercalated chemotherapy and tyrosine kinase inhibitors
by: Zwitter Matjaz, et al.
Published: (2017-07-01) -
Flavonoids as receptor tyrosine kinase inhibitors in lung cancer
by: Sareshma Sudhesh Dev, et al.
Published: (2023-11-01)